Literature DB >> 22843484

Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy.

Nilesh Mathuria1, Roderick Tung, Kalyanam Shivkumar.   

Abstract

Management of patients with nonischemic cardiomyopathy (NICM) and ventricular tachycardia (VT) remains challenging. The role of catheter ablation for VT continues to evolve for these patients. Prior reports have described the location of the arrhythmogenic substrate for patients with NICM to be frequently located along the basal left ventricle, with an epicardial predilection. Furthermore, predictors for identifying whether mapping the endocardium or epicardial surface of the heart have been identified for improved success of VT ablation in this patient population. This chapter will review the latest advances in catheter ablation of ventricular tachycardia in patients with NICM.

Entities:  

Mesh：

Year:  2012        PMID： 22843484      PMCID： PMC3766743          DOI： 10.1007/s11886-012-0302-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  33 in total

1.  Electrocardiographic recognition of the epicardial origin of ventricular tachycardias.

Authors:  Antonio Berruezo; Lluis Mont; Santiago Nava; Enrique Chueca; Eduardo Bartholomay; Josep Brugada
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

2.  A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results.

Authors:  L Gepstein; G Hayam; S A Ben-Haim
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

3.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.

Authors:  F E Marchlinski; D J Callans; C D Gottlieb; E Zado
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

4.  Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.

Authors:  Pasquale Vergara; Nicola Trevisi; Annalisa Ricco; Francesco Petracca; Francesca Baratto; Manuela Cireddu; Caterina Bisceglia; Giuseppe Maccabelli; Paolo Della Bella
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-04

5.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

Authors:  K P Anderson; R Walker; P Urie; P R Ershler; R L Lux; S V Karwandee
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

7.  Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.

Authors:  Kyoko Soejima; William G Stevenson; John L Sapp; Andrew P Selwyn; Gregory Couper; Laurence M Epstein
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

8.  Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy.

Authors:  D V Unverferth; P B Baker; S E Swift; R Chaffee; J K Fetters; B F Uretsky; M E Thompson; C V Leier
Journal:  Am J Cardiol       Date:  1986-04-01       Impact factor: 2.778

9.  Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction.

Authors:  J M de Bakker; F J van Capelle; M J Janse; S Tasseron; J T Vermeulen; N de Jonge; J R Lahpor
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

10.  Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin.

Authors:  D D Sugrue; D R Holmes; B J Gersh; W D Edwards; C J McLaran; D L Wood; M J Osborn; S C Hammill
Journal:  J Am Coll Cardiol       Date:  1984-11       Impact factor: 24.094
View more
  3 in total

Review 1.  Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.

Authors:  Kalyanam Shivkumar; Olujimi A Ajijola; Inder Anand; J Andrew Armour; Peng-Sheng Chen; Murray Esler; Gaetano M De Ferrari; Michael C Fishbein; Jeffrey J Goldberger; Ronald M Harper; Michael J Joyner; Sahib S Khalsa; Rajesh Kumar; Richard Lane; Aman Mahajan; Sunny Po; Peter J Schwartz; Virend K Somers; Miguel Valderrabano; Marmar Vaseghi; Douglas P Zipes
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

2.  Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction.

Authors:  Marmar Vaseghi; Siamak Salavatian; Pradeep S Rajendran; Daigo Yagishita; William R Woodward; David Hamon; Kentaro Yamakawa; Tadanobu Irie; Beth A Habecker; Kalyanam Shivkumar
Journal:  JCI Insight       Date:  2017-08-17

Review 3.  Management of Arrhythmias in Heart Failure.

Authors:  Daniele Masarone; Giuseppe Limongelli; Marta Rubino; Fabio Valente; Rossella Vastarella; Ernesto Ammendola; Rita Gravino; Marina Verrengia; Gemma Salerno; Giuseppe Pacileo
Journal:  J Cardiovasc Dev Dis       Date:  2017-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.